235 related articles for article (PubMed ID: 15166217)
1. Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression.
Choudhury AD; Xu H; Baer R
J Biol Chem; 2004 Aug; 279(32):33909-18. PubMed ID: 15166217
[TBL] [Abstract][Full Text] [Related]
2. The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.
Wu-Baer F; Ludwig T; Baer R
Mol Cell Biol; 2010 Jun; 30(11):2787-98. PubMed ID: 20351172
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
Hayami R; Sato K; Wu W; Nishikawa T; Hiroi J; Ohtani-Kaneko R; Fukuda M; Ohta T
Cancer Res; 2005 Jan; 65(1):6-10. PubMed ID: 15665273
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase.
Nishikawa H; Ooka S; Sato K; Arima K; Okamoto J; Klevit RE; Fukuda M; Ohta T
J Biol Chem; 2004 Feb; 279(6):3916-24. PubMed ID: 14638690
[TBL] [Abstract][Full Text] [Related]
5. Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells.
Choi YH
Int J Oncol; 2001 Oct; 19(4):687-93. PubMed ID: 11562742
[TBL] [Abstract][Full Text] [Related]
6. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
[TBL] [Abstract][Full Text] [Related]
7. Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.
Sato K; Hayami R; Wu W; Nishikawa T; Nishikawa H; Okuda Y; Ogata H; Fukuda M; Ohta T
J Biol Chem; 2004 Jul; 279(30):30919-22. PubMed ID: 15184379
[TBL] [Abstract][Full Text] [Related]
8. The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin.
Wu-Baer F; Lagrazon K; Yuan W; Baer R
J Biol Chem; 2003 Sep; 278(37):34743-6. PubMed ID: 12890688
[TBL] [Abstract][Full Text] [Related]
9. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.
Chen A; Kleiman FE; Manley JL; Ouchi T; Pan ZQ
J Biol Chem; 2002 Jun; 277(24):22085-92. PubMed ID: 11927591
[TBL] [Abstract][Full Text] [Related]
10. Kip1 degradation via the ubiquitin-proteasome pathway.
Tam SW; Theodoras AM; Pagano M
Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains.
Jin Y; Xu XL; Yang MC; Wei F; Ayi TC; Bowcock AM; Baer R
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12075-80. PubMed ID: 9342365
[TBL] [Abstract][Full Text] [Related]
12. Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function.
Sankaran S; Starita LM; Simons AM; Parvin JD
Cancer Res; 2006 Apr; 66(8):4100-7. PubMed ID: 16618730
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitination and proteasome-mediated degradation of BRCA1 and BARD1 during steroidogenesis in human ovarian granulosa cells.
Lu Y; Amleh A; Sun J; Jin X; McCullough SD; Baer R; Ren D; Li R; Hu Y
Mol Endocrinol; 2007 Mar; 21(3):651-63. PubMed ID: 17185394
[TBL] [Abstract][Full Text] [Related]
14. Degradation of transcription repressor ZBRK1 through the ubiquitin-proteasome pathway relieves repression of Gadd45a upon DNA damage.
Yun J; Lee WH
Mol Cell Biol; 2003 Oct; 23(20):7305-14. PubMed ID: 14517299
[TBL] [Abstract][Full Text] [Related]
15. Nuclear targeting and cell cycle regulatory function of human BARD1.
Schüchner S; Tembe V; Rodriguez JA; Henderson BR
J Biol Chem; 2005 Mar; 280(10):8855-61. PubMed ID: 15632137
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.
Morris JR; Solomon E
Hum Mol Genet; 2004 Apr; 13(8):807-17. PubMed ID: 14976165
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner.
Zhao J; Tenev T; Martins LM; Downward J; Lemoine NR
J Cell Sci; 2000 Dec; 113 Pt 23():4363-71. PubMed ID: 11069780
[TBL] [Abstract][Full Text] [Related]
18. The BRCA1/BARD1 ubiquitin ligase and its substrates.
Witus SR; Stewart MD; Klevit RE
Biochem J; 2021 Sep; 478(18):3467-3483. PubMed ID: 34591954
[TBL] [Abstract][Full Text] [Related]
19. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
[TBL] [Abstract][Full Text] [Related]
20. HERC2 is an E3 ligase that targets BRCA1 for degradation.
Wu W; Sato K; Koike A; Nishikawa H; Koizumi H; Venkitaraman AR; Ohta T
Cancer Res; 2010 Aug; 70(15):6384-92. PubMed ID: 20631078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]